Immunological differences between atopic dermatitis, psoriasis, and their combination in adult patients

Main Article Content

Magdalena Krupka-Olek
Andrzej Bozek
Milena Drewienkowska
Krzysztof Dryjka
Agata Medrala

Keywords

Atopic Dermatitis, Cytokine, Immunoglobulin E, Lymphocytes, Psoriasis

Abstract

Objectives: The simultaneous occurrence of psoriasis (PS) dominated by Th1 lymphocytes and atopic dermatitis (AD) driven by Th2 cells is rare. This study analyzed a group of adult patients with concomitant PS and AD (ADPS) and compared the cytokine profiles of these patients with those of subjects with homogenous PS or AD and healthy controls.


Materials and methods: All patients underwent dermatological examinations, including assessment of Scoring Atopic dermatitis (SCORAD) index and Psoriasis Area Severity Index (PASI) scores, TNF-α, IFN-γ, Il-2, Il-4, Il-5, Il-6, Il-8, Il-12, I-17A, Il-18, Il-22, Il-33, and T. There were 39 patients with a diagnosis of ADPS, 45 patients with PS, 47 patients with AD, and 42 healthy controls.


Results: Patients with ADPS were mainly men with a proportional distribution of skin lesion areas. Significant differences were observed in the concentration of Il-17A between patients with ADPS and those with AD or PS and controls, which were as follows: 16.1 ± 5.4, 5.8 ± 2.1, 5.0 ± 3.1, and 3.3 ± 1.8 pg/mL, respectively. In conclusion, AD and PS might coexist as a combination disease. The role of T helper 17 cells may be more essential than previously thought.

Abstract 352 | PDF Downloads 248 HTML Downloads 39 XML Downloads 7

References

1. Eyrich SE, Onken AT, Weidinger S, Franke A, Nasorri F, Pennino D, et al. Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med. 2011;365:231–8. 10.1056/NEJMoa1104200

2. Guttman-Yassky E, Krueger JG. Atopic dermatitis and psoriasis: Two different immune diseases or one spectrum? Curr Opin Immunol. 2017;48:68–73. 10.1016/j.coi.2017.08.008

3. Guttman-Yassky E, Krueger JG, Lebwohl MG. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment. Exp Dermatol. 2018;27:409–17. 10.1111/exd.13336

4. Kapila S, Hong E and Fischer G. A comparative study of childhood psoriasis and atopic dermatitis and a greater understanding of the overlapping condition, psoriasis--dermatitis. Austr J Dermatol. 2012;55:98–105. 10.1111/j.1440-0960.2012.00878.x

5. Bozek A, Zajac M, Krupka M. Atopic dermatitis and psoriasis as overlapping syndromes. Mediators Inflamm. 2020;27:7527859. 10.1155/2020/7527859

6. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venerol. Suppl. 1980;92:44–7. 10.2340/00015555924447

7. Altobelli E, Petrocelli R, Marziliano C, Fargnoli MC, Maccarone M, Chimenti S, et al. Family history of psoriasis and age at disease onset in Italian patients with psoriasis. Br J Dermatol. 2007;156:1400–1. 10.1111/j.1365-2133.2007.07906.x

8. Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet 2021;3;397(10281):1301–15. 10.1016/S0140-6736(20)32549-6

9. Available from: www.thermofisher.com/pl/en/home/life-science/antibodies/immunoassays/elisa-kits/cytokine-chemokine-growth-factor-elisa-kits.html [cited 2021 Oct 11].

10. Kouwenhoven TA, Bronckers IMGJ, van de Kerkhof PCM, Kamsteeg M, Seyger MMB. Psoriasis dermatitis: An overlap condition of psoriasis and atopic dermatitis in children. J Eur Acad Dermatol Venerol. 2019;33(11):e74–6. 10.1111/jdv.15716

11. Docampo A, Sanchez-Pujol MJ, Belinchon I, Miralles J, Lucas A, García L, et al. Response to letter to the editor: “Psoriasis dermatitis: An overlap condition of psoriasis and atopic dermatitis in children. J Eur Acad Dermatology Venerol. 2019;33:e395–436. 10.1111/jdv.15716

12. Asarch A, Barak O, Loo DS, Gottlieb AB. Th17 cells: A new therapeutic target in inflammatory dermatoses. J Dermatolog Treat. 2008;19(6):318–26. 10.1080/09546630802206660

13. Ogawa E, Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. J Dermatol. 2018;45(3):264–72. 10.1111/1346-8138.14139

14. Martel BC, Litman T, Hald A, Norsgaard H, Lovato P, Dyring-Andersen B, et al. Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis. Exp Dermatol. 2016;25(6):453–9. 10.1111/exd.12967

15. Klonowska J, Glen J, Nowicki RJ, Trzeciak M. New cytokines in the pathogenesis of atopic dermatitis—New therapeutic targets. Int J Mol Sci. 2018;19(10):3086. 10.3390/ijms19103086

16. Cabanillas B, Brehler AC, Novak N. Atopic dermatitis phenotypes and the need for personalized medicine. Curr Opin Allergy Clin Immunol. 2017;17(4):309–15. 10.1097/ACI.0000000000000376

17. Czarnowicki T, Esaki H, Gonzalez J, Malajian D, Shemer A, Noda S, et al. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets. J Allergy Clin Immunol. 2015;136:941–51. 10.1016/j.jaci.2015.05.049